@article{490a2f348e474de288d6b75bf2d5858e,
title = "Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung Cancer",
author = "Lam, {Vincent K.} and Forde, {Patrick M.}",
note = "Funding Information: Disclosure: Dr. Lam reports receiving personal fees from Seattle Genetics, Takeda Pharmaceuticals, and Bristol-Myers Squibb and grants from Bristol-Myers Squibb outside of the submitted work. Dr. Forde reports receiving grants and other fees from AstraZeneca and Bristol-Myers Squibb; other fees from Johnson & Johnson; and grants from Corvus and Kyowa outside of the submitted work.",
year = "2020",
month = oct,
doi = "10.1016/j.jtho.2020.08.013",
language = "English (US)",
volume = "15",
pages = "1556--1558",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "10",
}